Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BXL628 with or without tamsulosin for benign prostatic hyperplasia
2005-000154-76Phase 2Completed
- Sponsor
- Bioxell GmbH
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of elocalcitol in benign prostatic hyperplasia (BPH) (4 arms), sponsored by Bioxell GmbH. Started Dec 2005; status: completed.
02
Drugs
elocalcitol
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on 2005-000154-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000154-76.